Argentina's national pharmacovigilance system is coordinated by ANMAT and provides reporting routes for healthcare professionals, patients and regulated stakeholders.
Core official resources
- Sistema Nacional de Farmacovigilancia — ANMAT's central pharmacovigilance hub.
- Adverse-event reporting for healthcare professionals — route into the national reporting system.
- Adverse-event reporting for patients — patient reporting information.
Practical use
Use the ANMAT pharmacovigilance hub as the starting point for current national forms, reporting channels and safety communications. Company procedures should separately verify current obligations applicable to marketing-authorisation holders and product-specific requirements.